There are viral, fungal, bacterial and trypanosomal pathogens that negatively impact the individual and superorganismal health of the western honey bee. One fungal pathogen, Ascosphaera apis , affects larvae and causes the disease chalkbrood. A previous genome analysis of As. apis revealed that its genome encodes for RNA interference genes, similar to other fungi and eukaryotes. Here, we examined whether As.
Introduction
Ribonucleic acid interference (RNAi) is an evolved viral defense strategy in eukaryotic organisms which is likened to restriction enzymes in prokaryotes. It is also involved in host gene regulation. As a viral defense strategy, RNAi is a gene silencing mechanism that cleaves viral sequences, thus eliminating translation of the virus in the host. The host's canonical RNAi-related proteins ("machinery") include Dicer, Argonaute and RNA-dependent RNA polymerase proteins, and are found in both fungi and animals (Dang, Yang, Xue, & Liu, 2011; Hu, Stenlid, Elfstrand, & Olson, 2013) . Double-stranded RNA (dsRNA), a regular component of replication in many viruses, is recognized by Dicer, which cleaves this dsRNA into 21 to 25 nucleotide dsRNA fragments ("diced RNA"). A single strand from these dsRNA fragments guides Argonaute to the respective complementary viral sequence and cleaves this region. RNA-dependent RNA polymerase, when present, can amplify these RNA strands, thereby amplifying the RNAi response.
RNAi studies in insects, in particular the honey bee ( Apis mellifera ), have shown that the RNAi system can successfully be exploited to reduce pathogen titers. The honey bee possesses the necessary RNAi machinery. In the laboratory to activate and manipulate the RNAi response in bees, injection of dsRNA is one route, although feeding bees dsRNA appears to be a simpler and a successful method as well (Yang et al., 2018) . To demonstrate the importance of the RNAi antiviral defense response in bees, when honey bee transcripts of Dicer were knocked down using dsRNA, researchers observed an increase in viral titers in the host (Brutscher, Daughenbaugh, & Flenniken, 2017) . It is important to understand how to combat viral pathogens like Deformed wing virus (DWV) and Israeli acute paralysis virus (IAPV) because such viruses are linked to overwinter colony loss (Döke, Frazier, & Grozinger, 2015) .
Double-stranded RNA fed to honey bees with complementing sequences to DWV or IAPV led to reduced viral titers in the honey bee (Maori et al., 2009 ) . However, ambiguous dsRNA sequences, including even the non-complementary sequence of GFP , can also induce an RNAi antiviral defense or systemic suppression of transcripts in the honey bee (Flenniken & Andino, 2013) . RNAi has additionally been used against the parasite Nosema ceranae , an emerging honey bee spore-forming fungal parasite that is a significant cause of concern. In one case, dsRNA targeting the polar tube of N.
ceranae , which is used by N. ceranae to penetrate the host's epithelial cells to initiate its reproductive cycle, led to significantly fewer spores in the honey bee gut (Rodríguez-García et al., 2018) .
Interestingly, a host's own RNAi mechanism can be used against itself. For example, injecting beetles with beetle-targeting dsRNA helped researchers create a catalogue of essential/lethal genes as well as constituting experimental evidence that a gene was connected to a phenotype throughout the insect's development from egg to adult (Jasrapuria, Specht, Kramer, Beeman, & Muthukrishnan, 2012; Schmitt-Engel et al., 2015) . As noted above, fungi possess the necessary components for RNAi, in addition to other honey bee-associated pathogens. The opportunistic/pathogenic, spore-forming, ascomycetous fungi, Aspergillus and Fusarium , are perhaps the best studied organisms where researchers used RNA species to activate the RNAi mechanism in the fungus and thereby against itself (Baldwin et al., 2018; Kalleda, Naorem, & Manchikatla, 2013) . In this system, for example, germinating Aspergillus nidulans was introduced to diced RNA species that targeted putative Ras family genes for which some of the respective proteins are completely essential for growth and development (Kalleda et al., 2013) . A knockdown (and not knockout) of Ras transcripts led to reduced fungal growth. In this study, no special transfection method was done to transfer RNA into the cells, meaning that fungi can, in principle, actively uptake exogenous genetic material. This was in alignment with other studies that showed growing fungi take up exogenous genetic material and transfection reagents are unnecessary. However, increased effectiveness of gene silencing methods from the use of such reagents may be areas for future improvements regarding this technology. In A.
fumigatus , the uptake of exogenous RNA was recorded over a period of two hours during germination (Jöchl, Loh, Ploner, Haas, & Hüttenhofer, 2009 ) . In another model organism, Pecoramyces ruminantium (Division: Neocallimastigomycota), the uptake of exogenous dsRNA by germinating spores occurred within just 15 minutes after its introduction to the activated spores (Calkins et al., 2018) .
Ascosphaera apis ( As. apis ) is a fungal pathogen of the honey bee that causes the disease chalkbrood (reviewed in (Aronstein & Murray, 2010) ). Spores of this fungus are ingested by larvae which then germinate in the gut where the anaerobic environment activates/stimulates spore germination. When the spore is activated for germination, it undergoes physical changes such as swelling and then the emergence of a primary germ tube. During outgrowth in the larva, the hyphae breaches the gut epithelial cell wall, followed by the larval body, altogether leading to the visual characteristic of a "mummified" larva. This does not occur in adults. The As. apis genome is known to encode the RNAi machinery (Cornman et al., 2012) . While chalkbrood may currently be less concerning than other emerging infectious honey bee diseases such DWV or Nosema , As. apis can nonetheless reduce brood levels in infected colonies. Particularly in colonies already weakened by infections with other pathogens, chalkbrood can potentially and additively threaten the long-term survival of these colonies. This is in addition to other possible effects from other filamentous fungi ( e.g ., Stonebrood disease; (Jensen et al., 2013) or yeasts (Tauber, Nguyen, Lopez, & Evans, 2019) ).
As honey bees are affected by a multitude of stressors and pathogens, it is important to seek remedies against all pathogens. To this end, we hypothesized that RNAi may be applicable against As. apis as described in other fungi. Activated As. apis spores were introduced to Ras family and also cell wall synthesis targeting dsRNA which we presumed to be essential for growth and development. We observed a reduced number of germinating spores when As. apis was exposed to these As.
apis -targeting dsRNA. We believe that this establishes a platform for exploiting the RNAi machinery of As. apis , and possibly synergistically with that of the honey bee, to combat this pathogen as well as to discover, beyond sequencing projects, virulence factors that this fungus utilizes during host infection.
Materials and Methods

Fungal strains, growth and spore production
Two mating-compatible, species-confirmed Ascosphaera apis strains (AFSEF 7405 and ARSEF 7406) were ordered from the ARS Collection of Entomopathogenic Fungal Cultures, USDA-ARS (NY, USA) as actively growing cultures. An agar plug containing As. apis mycelia was plated onto potato dextrose 1.8% agar (Roth) to make working plates, and the plates were sealed with PARAFILM ® M, wrapped in aluminum foil and grown at 30°C under aerobic conditions. One agar plug from each mating strain working plate that contained actively growing cultures was then placed across from one another on a similar plate, which was incubated, as described in (Jensen et al., 2013) , in order to produce spores. After three to four weeks of growth, the interaction zone between the two strains appeared pigmented, indicating the production of spores. The spores generally do not activate or germinate on agar after they are produced without CO 2 stimulation. About 1 ml of autoclaved dH 2 0-tween (one droplet of Tween ® 80 per 500 ml water) was added on top of the interaction zone, the spores scraped into the solution and then the solution was collected into a sterile plastic centrifuge tube. This was repeated on the same plate. Multiple plates were also incubated in parallel. The spore suspensions were grounded using a sterile plastic pestle. This suspension was
filtered through a sterile folded cheese cloth. The spores were mixed with 50% sterile glycerol in dH 2 0 to create a 25% glycerol stock and the concentration of spores were then counted in a Neubauer improved chamber (BLAUBRAND ® ) using 10 μl of the stock. The stock was stored at -70°C until thawed as needed for experiments.
Cloning and dsRNA production
Our original goals were to i) modify plasmid L4440 and produce dsRNA in E. coli (Solis, Santi-Rocca, Perdomo, Weber, & Guillén, 2009) ; ii) produce dsRNA that targeted putative Ras family genes and other genes like cell wall synthesis that are likely essential/lethal, as done in Aspergillus nidulans (Kalleda et al., 2013) ; iii) use the RNAi machinery of the fungus rather than the bee host to induce an RNAi effect, similar to A.
nidulans and other filamentous fungi (Cornman et al., 2012; Dang et al., 2011) ; and iv) introduce dsRNA to the spores as-is because we presumed that germinating spores will uptake or bind to exogenous genetic material upon CO 2 activation and without the need for transfection reagents, as observed in other fungi and microorganisms (Calkins et al., 2018; de Sousa Pereira, Piot, Smagghe, & Meeus, 2019; Jöchl et al., 2009) . To this end we searched the most recent As. apis ARSEF reference genome (Shang et al., 2016) for predicted Ras family and glucan synthesis proteins using keywords within NCBI. We selected the following proteins: 'Ras GTPase-activating-like protein rng2' (KZZ95061.1;
Ras gene) and '1,3-beta-glucan biosynthesis protein' ( KZZ95811.1 ; beta-glucan gene).
When aligning the primary protein sequences of these two proteins in NCBI's blastp there was 35% coverage with 46.81% identity. To clone partial sequences of these genes, total RNA was isolated from As. apis mycelia from an actively growing culture using the Quick-RNA™ Miniprep Kit (Zymo Research). Complementary DNA (cDNA) was produced using ProtoScript ® II Reverse Transcriptase (NEB) for 2 hours at 48°C from an aliquot of the total RNA isolate and priming with d(T) 20 VN; otherwise the manufacturer's recommend reaction mixture was used. The cDNA was diluted 1:1 with nuclease-free water and used in Q5 ® High-Fidelity DNA Polymerase (NEB) reactions (as recommended by the manufacturer) using the following primer pairs (listed in the 5' to 3' direction). Primers were developed within the online tool Primer-BLAST (Ye et al., 2012) using the database's cds sequence from the two genes (Ras gene: F: CCTGCAATGGTTTGTGGACG, R: ATTCAGCCTGAGGTTCCTGC, expected: 422 bp;
and beta-glucan: F: TTGGCGTGGGTACTTCTTCC , R: TTTACCGTTGTTTGCGCCAG , expected: 542 bp). The partial gene was then checked against the current honey bee genome ( GCA_003254395.2 Amel_HAv3.1 ) within NCBI. An aliquot of the PCR mixture was run in a 1.0% agarose gel (Agarose NEEO Ultra-Quality (Roth)) in 0.5 × TAE buffer to check that the amplicons were of proper size by molecular weight. Our amplified cds sequence of the beta-glucan gene showed one misannotated intron after sequencing (described later), but initially noted by a different expected bp size in the gel (actual amplified length = 455 bp were added to the T7 reaction mixture, and the mixture further incubated for 45 minutes at 37°C to remove DNA. We then used SureClean Plus (Bioline) to purify the dsRNA as this purification method is a "non-toxic alternative" and probably does not have any residual toxic chemicals ( e.g ., as potentially with TRIzol ® ), an important consideration when using the suspension for experiments with an organism (personal communication with the company). We followed the recommended SureClean Plus protocol except that the centrifugation steps were done at 15,000 rpm and for 15-30 minutes, we used 75% ethanol, we did not vortex (only flicking) the RNA and the large white pellet was suspended in 50 μl sterile dH 2 0. An aliquot of the T7 transcription reaction (before and after purification) was run in a 2.0% agarose gel using GelRed ® Nucleic Acid Gel Stain (Biotium) as above to confirm the production of dsRNA. We used a 100 bp dsDNA (not dsRNA) ladder (Fermentas); therefore, the size in bp could only be estimated. The concentration of RNA was measured by Nanodrop (Thermo). The purity had acceptable values (A 260/280 > 2.0 and A 260/230 > 2.0 in all cases after purification). The dsRNA was used fresh for the experiment as well as from an one-time frozen-thawed aliquot. A mock water SureClean Plus extraction was used for control treatments and this extraction did not produce any bands in the gel nor a spectral readout from the Nanodrop.
As . apis in vitro tests
To start the in vitro tests we first thawed one aliquot of the glycerol spore suspension.
To uniformly distribute an equal number of spores per sample, we first made a master mix of the spores, medium and antibiotic (as the preparation was done outside of a laminar flow hood), and then vortexed the mixture frequently while aliquoting the 49 μl spore master mix per 700 μl tube, after which the tubes were randomly assigned a sample code. The final reaction mixture contained 20 μl of the As. apis glycerol spore stock, 24 μl of Sabouraud Dextrose broth (Roth), 5 μl of ampicillin-salt (50 μg/mL final concentration, Carl Roth) and approximately 30-32 nM dsRNA (that is, approximately 0.7 to 1 μl of the dsRNA-water solution amended with sterile water to 1 μl when required). A water suspension from a mock SureClean Plus extraction was used in lieu of dsRNA for the positive and negative controls. In total, there were five treatments: a positive control (mock extraction and + CO 2 ), a negative control (mock extraction and -CO 2 ), As. apis with Ras gene dsRNA (+ CO 2 ), As. apis with beta-glucan gene dsRNA (+ CO 2 ) and an unrelated dsRNA control (+ CO 2 ), and the treatments were always run in parallel with one another per trial and in duplicate or quartet. For the unrelated dsRNA control, we used a non-ribosomal peptide synthetase-like gene ( NPS3 ) from an unrelated fungus, the basidiomycete Serpula lacrymans (a reference strain at the BAM Institute), and this gene shares no similarity with genes from As. apis by blastn. The molecular techniques to create the NPS3 dsRNA control were exactly like the procedures for the other partial genes (EGO23141.1: F: TTCCGTGCTCGTGGATTTGA, R: AGCTTCTCCGGTGTCAACTG, expected: 419 bp).
It is well established that a flush of CO 2 activates spores and it is the most reliable way to active spores for germination (Heath & Gaze, 1987) . Therefore, we placed the sample-coded tubes with their lids opened and in a randomly assorted array into a sealable plastic container and flushed the container for 15 seconds with CO 2 (Linde Gas). The tubes with opened lids were incubated in the container for 15 minutes, a modified version of the 'flush method' set out in (Heath & Gaze, 1987) . This was followed by one additional CO 2 flush and then the tube lids were immediately closed.
The tubes were placed at 30°C (at this point, CO 2 concentration was not measured and the spores were exposed to light). A remaining aliquot of prepared spores was examined by microscopy at the onset of the experiment; in each trial we observed that the spores at the beginning of the experiment were unactivated and appeared like the negative control throughout the experiment (see Results).
Approximately 24-26 hours later, spores were counted as carried out before for Ascosphaera apis (Heath & Gaze, 1987) and Ascosphaera aggregata (Goettel, Duke, Schaalje, & Richards, 1992 ) germination counts. The tube was vortexed for 5 seconds, the solution pipetted up and down three times and then 10 μl was loaded into a Neubauer improved chamber and allowed to settle for two minutes. Counting of activated and unactivated spores was observed at 400 × with phase contrast.
Unactivated versus activated spores were easily distinguished from one another using two observations: 1) a change in morphology ( i.e ., during the activation, there is an initial swelling of the spore that occurs before tube germination and can be seen one day after flushing CO 2 ); and 2) a change in the contrast of the spore: a) the unactivated spores appear as bright, highly refractive bodies, similar to Nosema spp. spores using the same microscopy techniques (Tauber, Collins, et al., 2019) , and b) the difference in the brightness of activated and unactivated spores appears similar to Ascosphaera aggregata (Stephen, Vandenberg, Fichter, & Lahm, 1982) .
Statistics
Within the hemocytometer we counted unactivated and activated spores in two separate 1 mm × 1 mm counting chambers per tube. Each treatment had two to four replicates that were run in parallel per trial and the experiment was repeated four times, totaling 24 replicate counts per treatment. We summed the counts per treatment across all trials for both activated and unactivated spores, and initially ran a Chi-squared test followed by 2×2 Fisher's exact tests (treatment versus activated/unactivated). Calculations were done online using the tools provided on www.socscistatistics.com (accessed 2019).
Unactivated spore proportions (number of unactivated spores over total spores counted in one counting chamber (1 counting chamber count = 1 data point)) between treatments were then compared. Based on these outputs, we proceeded to create a mixed model in order to compensate for possible random effects and to determine statistical significance between treatments of unactivated spore proportions. To this end, we created a generalized linear mixed model with a beta family distribution using default parameters as follows. First, 1e-6 was subtracted from every proportion before modeling. The model and statistics were calculated in RGui (3.6.1, 32-bit PC) using these packages: glmmTMB, effects, emmeans, multcomp, car, lme4 and glht. For the model, the unactivated spore count proportion was the dependent variable; the treatment was a fixed effect; and the trial, fungal glycerol stock preparation and dsRNA-T7 RNA polymerase reaction mixture (produced in vitro at two different times)
were random variables. The final model included every noted factor. We independently tested each possible factor on treatment (described in the Results) for which interactions were found to be not statistically significant. Lastly, a multiple pairwise comparison of the model was done by the Tukey test with a Bonferroni correction. The alpha level was set at .05 in all cases and when P was less than .05 we considered the outcome to be statistically significant ( i.e ., we rejected that there was no difference/association between As. apis -targeting dsRNA and spore activation). Graphs were made online using the Plotly graphing platform available on chart-studio.plot.ly/ (accessed 2019).
Results
We counted activated and unactivated As. apis spores that were incubated in the presence of Ras family or beta-glucan targeting dsRNA, unrelated dsRNA (control) or a mock control (blank water). The null hypothesis was that there was no association/difference between the first step in As. apis spore germination ( i.e ., activation) and the presence of dsRNA. The 5×2 Chi-squared test of the five treatments and two categories of activated or unactivated spore counts revealed a significant difference between one or more of the two treatments (χ 2 = 6214.8899, df = 4, P < 0.00001), likely either due to lack of CO 2 as expected for the negative control or from one of the dsRNA treatments (alternative hypothesis). 2×2 Fisher's exact tests were then used where each treatment was compared to the positive control. Here, we observed statistically significant associations between CO 2 ( i.e ., with the negative control) and the active state of the spore ( P < 0.00001), as well as between the active state of the spore and each As. apis -targeting dsRNA (each, P < 0.00001). This was not observed, however, for the unrelated dsRNA control ( P = .6740). Additionally, the average and median of unactivated spore proportions in the As. apis dsRNA Ras gene treatment (average =0.3031 and median =0.2964) and As. apis dsRNA beta-glucan gene treatment (=0.4026 and =0.3325) were higher than the positive control (=0.2572 and =0.2621) and also the unrelated dsRNA control (=0.2621 and =0.2545); all were lower than the negative control (=0.9893 and =0.9921).
Given these results, we chose to model and test the means of the groups because it appeared likely that the presence of As. apis -targeting dsRNA was responsible for the difference in proportions. We initially tested the model by checking for experimental effects on the treatments: the date that the dsRNA reaction mixtures were produced indicated no statistically significant interaction with the treatments (χ 2 = 2.65, df = 4, P = .6188); the independent date that the trial was performed was not significant although a possible interaction with the treatment was observed (χ 2 = 18.82, df = 12, P = .0930); and the fungal stock used had no statistically significant interaction with the treatments (χ 2 = 6.00, df = 8, P = .6481).
We observed a statistically significant average higher proportion of unactivated spores when As. apis beta-glucan dsRNA was co-incubated with the spores compared to the positive control ( P < .0001; Figure 1) . The model-derived estimated marginal means computed with 95% confidence intervals confirmed that these two treatments did not overlap (positive control: = -1.054 ± 0.123 SE; CI 95% [-1.298, -0.811]; and As. apis dsRNA beta-glucan gene treatment: = -0.407 ± 0.118 SE; CI 95% [-0.642, -0.173]). We also removed seven non-statistically significant (via the Grubbs' test),
higher-than-average unactivated As. apis proportion data points from the As. apis beta-glucan gene dsRNA treatment. After removing these seven data points from the As. apis beta-glucan gene dsRNA treatment and rerunning the exact same statistical analyses, the resulting model-, multiple comparison (Tukey)-, Bonferroni-derived result remained statistically significant (Positive control vs. modified As. apis beta-glucan gene dsRNA treatment: P = .0057; Figure 1) . The negative control that did not receive CO 2 showed almost no activated spores the next day. were swelling spores (a halo was observed around all the spores). For analysis, we used spore counts 24 hours after introducing CO 2 and the dsRNA.
Discussion
Ascosphaera apis is part of the honey bee pathosphere (Schwarz, Huang & Evans, 2015) and should be considered when attempting to combat the many pathogens and stressors undermining honey bee populations. As. apis is prevalent when screened by PCR-based surveys. For example, a comprehensive survey on honey bee products in Brazil noted that 73.17% of the tested samples were contaminated with As. apis (compared to 87.80% from N. ceranae ) (Teixeira et al., 2018) . Although the relative severity of As. apis is not considered to be as alarming as that of N. ceranae , DWV or
Paenibacillus larvae (American foulbrood disease), its high prevalence, ability to cross-contaminate amongst bees , deterrent effect for bee pollination (Yousefi & Fouks, 2019) , and potential to inflict damage on both healthy as well as weakened colonies indicate a need to further develop As. apis control strategies.
Other honey bee RNAi experiments have also shown success in reducing pathogen loads (reviewed in (Brutscher & Flenniken, 2015) ). RNAi strategies against viruses were successful, at least under controlled laboratory conditions. In two separate studies, dsRNA targeting DWV caused a reduction in DWV titers (Desai, Eu, Whyard, & Currie, 2012; Ryabov et al., 2014) . Similarly, one study showed a reduction in IAPV after feeding IAPV-targeting dsRNA to bees (Maori et al., 2009 ) . Interestingly, researchers noted a reduction in IAPV levels from a large-scale study using 160 hives and bulk feeding of RNAi molecules targeting IAPV (Hunter et al., 2010) . For N.
ceranae , knocking down the transcripts of polar tube protein 3 and incubating the bees with Nosema for ten days led to a reduction in counted spores (Rodríguez-García et al., 2018) . This was also the case when targeting N. ceranae Dicer as well as ADP/ATP transporters (the latter, as measured by 16s rRNA transcripts) Paldi et al., 2010) . A recent study used dsRNA to target the gut parasite trypanosomatid, Crithidia mellificae , ex vivo ( i.e ., tested outside of a bee host) (de Sousa Pereira et al., 2019) . The researchers selected a conserved, likely essential gene for the microorganism, produced dsRNA targeting this gene and introduced the dsRNA via three methods (electroporation into the cells, transfection by a reagent or simply adding the dsRNA to the medium containing the cells). They observed that there was a marginal reduction in growth rate when the dsRNA was simply added to the medium and this reduction was dependent on cell density. Our methods were similar to the C. ). Based on these experiments with fungi, the use of transfection reagents or a special delivery system appears unnecessary and that fungi will uptake various RNA species (single-stranded or double-stranded) of any sequence. Based on these studies and our own, we speculated that upon activation but before swelling, As. apis already began to uptake nutrients as well as exogenous RNA species. Additionally, these noted experiments tested whether the microorganism will selectively self-inflict damage, thus reducing the transcripts of the gene of interest. This was similar to our experiment where it appeared that the fungus negatively acted on itself causing the spore to not proceed to swell even after the introduction of CO 2 . We tested dsRNA targets against annotated Ras family protein and beta-glucan genes as these genes are putatively essential and lethal when knocked out, at least in other fungi.
As noted in Pecoramyces ruminantium , uptake of exogenous dsRNA in activated spores can happen very quickly (measured in the study at 15 minutes from the onset of activation with potential that uptake happened sooner).
Moving forward, in vivo host tests require great care in order to reduce or eliminate any possible side effects of the dsRNA. On the one hand, ambiguous dsRNA sequences can already induce an RNAi antiviral defense response in the bee (Flenniken & Andino, 2013) . On the other hand, researchers must carefully design their dsRNA sequences to mitigate off-target effects. For example, even the use of GFP sequences, which have limited similarity to the A. mellifera genome, can result in systemic unintended changes in gene expression in the host (Jarosch & Moritz, 2012; Nunes et al., 2013) . Moreover, improved knockdown approaches such as delivery systems should not be discarded as they may further increase the efficiency of RNAi inhibition, and possible synergy with the bee host RNAi defense system ( i.e ., tested in vivo ) may also improve the pathogen control outcomes. Although use of dsRNA ex vivo and in vivo has been successfully used to control DWV, IAPV, N. ceranae , C. mellificae and now As. apis , its success on a large scale, namely in a commercial setting, remains to be determined. Additionally, there is always an evolutionary arms race between combating the pathogen and escape of the pathogen from any selective pressure. For example, DWV appears to infect or replicate as a recombinant pool of genotypes, thus the current RNAi methods need to keep pace with the varying sequences of DWV (namely, researchers must be concerned that the chosen dsRNA sequence will lose efficacy as the complementary viral sequence changes, as already observed in bees (Ryabov et al., 2019) ). Therefore, a combination of intelligently-designed, diverse and synergistic honey bee disease strategies from apicultural management practices to scientific advancements, will eventually and undoubtedly lead to improved honey bee-dependent agriculture. This will also improve our understanding of insect host immunity and virulence factors. Overall, we rejected our null hypothesis and concluded that the presence of As. apis -targeting dsRNA can negatively impact spore activation.
Conclusion
Ascosphaera apis is a honey bee-associated fungal pathogen and as of yet there has not been an RNAi control strategy developed against this fungus. We found that if we incubated As. apis spores with As. apis -targeting dsRNA, then we observed a higher proportion of unactivated spores, suggesting that the presence of dsRNA inhibited, at least partially, the swelling/initial germination stage of the spores. Therefore, researchers may be able to exploit the RNAi mechanism of As. apis , and potentially in synergy with honey bee's own RNAi machinery, to test fungal virulence factors and develop pathogen control strategies.
